4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001415889-24-020785
EVP, GLOBAL SALES sold 33,333 shares at an average $4.44 ($148,135)
- EVP, GLOBAL SALES acquired 33,333 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ross Thomas M. EVP, GLOBAL SALES | 2024-08-01 | Option exercise 10b5-1 | +15,476 | $1.64 | $25,396 | 40,476 | D |
| Ross Thomas M. EVP, GLOBAL SALES | 2024-08-01 | Sale 10b5-1 | −15,476 | $4.54 | $70,261 | 25,000 | D |
| Ross Thomas M. EVP, GLOBAL SALES | 2024-08-02 | Option exercise 10b5-1 | +17,857 | $1.64 | $29,303 | 42,857 | D |
| Ross Thomas M. EVP, GLOBAL SALES | 2024-08-02 | Sale 10b5-1 | −17,857 | $4.36 | $77,874 | 25,000 | D |
| Derivatives | |||||||
| Ross Thomas M. EVP, GLOBAL SALES | 2024-08-01 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −15,476 | 17,858 | D | ||
| Ross Thomas M. EVP, GLOBAL SALES | 2024-08-02 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −17,857 | 1 | D | ||
| Open-market sales · 33,333 sh · avg $4.44 · $148,135 | |||||||
Loading xslF345X05/form4-08052024_100803.xml…